Genmab A (GMAB) Income from Continuing Operations (2023 - 2026)
Genmab A (GMAB) posted Income from Continuing Operations of $303 million for the quarter ended Jun 30, 2026, down 19.0% from the prior quarter.
Powered by 
Analysis
Genmab A (GMAB) Income from Continuing Operations (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Continuing Operations at Genmab A was $2.7 billion; for the year ended Dec 31, 2025, it was $963 million, down 21.1% from the prior year.
- Annual Income from Continuing Operations shows a five-year compound annual growth rate of 13.9% (years ended Dec 2020 to Dec 2025).
- In prior years, Genmab A's Income from Continuing Operations was $1.22 billion in the year ended Dec 31, 2024 (+45.6%), $838.53 million in the year ended Dec 31, 2023 (-24.9%), $1.12 billion in the year ended Dec 31, 2022 (+186.6%) and $389.61 million in the year ended Dec 31, 2021 (-22.5%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Income from Continuing Operations since the quarter ended Jun 30, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -246.00 Mn |
| 10 | Genmab A | 2.57 Bn | -2.81 Bn | 1.07 Bn | 303.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 303.00 Mn |
| Mar 31, 2026 | 75.00 Mn |
| Sep 30, 2025 | 482.00 Mn |
| Jun 30, 2025 | 336.00 Mn |
| Mar 31, 2025 | 244.00 Mn |
| Sep 30, 2024 | 253.00 Mn |
| Jun 30, 2024 | 203.00 Mn |
| Mar 31, 2024 | 249.00 Mn |
| Dec 31, 2023 | -3.81 Bn |
| Sep 30, 2023 | 2.67 Bn |
| Mar 31, 2023 | 266.00 Mn |
API Access
Genmab A Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=GMAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "GMAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=GMAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();